Carcinoma, Hepatocellular: all 3,251 studies
Page 10 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Neo-TACE-HAIC for High-risk BCLC A Stage HCC (NeoconceptA)RecruitingNCT04777942Not applicable
- Intra-tumor Injection of Drug-eluting Microspheres With Multiple DrugsRecruitingNCT04770207Phase 2
- Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)RecruitingNCT04745403Phase 1
- Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver CancerRecruitingNCT04745390Not applicable
- Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;RecruitingNCT04738188Not applicable
- Comparison of HBV Reactivation Between Patients With High HBV-DNA and Low HBV-DNA Loads Undergoing ICI and Concurrent Antiviral Prophylaxis: a Prospective Observational StudyRecruitingNCT04680598
- LANDscape MApping of Epitopes and T Cell Receptors for Selected CancersRecruitingNCT04665388
- Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCCRecruitingNCT04663035Phase 2
- ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular CarcinomaRecruitingNCT04634357Phase 1/2
- Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCCRecruitingNCT04615143Phase 2
- Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma Beyond Milan/UCSF Criteria Who Underwent Liver TransplantationRecruitingNCT04595864Phase 3
- Neoadjuvant Hypofractionated Stereotactic Body Radiation Therapy Prior to Surgery for Hepatocellular Carcinoma: a Feasibility Study.RecruitingNCT04587739Phase 1
- Expanded Access to Ulixertinib (BVD-523) in Patients With Advanced MAPK Pathway-Altered MalignanciesAvailableNCT04566393
- FAST (Focused Abbreviated Screening Technique)-MRI StudyEnrolling by invitationNCT04539717
- Liver Disease and Other Systemic DiseasesRecruitingNCT04525833
- The Combination Therapy of TACE and Ablation With Durvalumab in Hepatocellular Carcinoma at Intermediate Stage (TAD)Not yet recruitingNCT04517227Not applicable
- HepatoPredict Prognostic Tool for the Decision of Liver Transplant in Hepatocellular CarcinomaRecruitingNCT04499833Not applicable
- Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular CarcinomaRecruitingNCT04472767Phase 2
- HCC Surveillance: Comparison of Abbreviated Non-contrast MRI and Ultrasound Surveillance in Cirrhotic Patients With Suboptimal Ultrasound VisualisationRecruitingNCT04455932Not applicable
- Durvalumab and Lenvatinib in Participants With Locally Advanced and Metastatic Hepatocellular Carcinoma ( Dulect2020-1 )RecruitingNCT04443322Not applicable
- SBRT Versus Ablation for Perivascular Hepatocellular CarcinomaRecruitingNCT04434989Not applicable
- Durvalumab With/Without Tremelimumab After Palliative Hypofractionated Radiotherapy for Hepatocellular CarcinomaRecruitingNCT04430452Phase 2
- Neo-TACE-HAIC for BCLC B Stage HCCRecruitingNCT04424043Not applicable
- A Study of Laparoscopic Middle Hepatic Vein Guidance and Traditional Anatomic HemihepatectomyRecruitingNCT04422249Not applicable
- Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular CarcinomaRecruitingNCT04414956Not applicable
- Patient-Derived Xenografts to Reduce Cancer Health DisparitiesRecruitingNCT04410302
- Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar CancerRecruitingNCT04380545Phase 1/2
- Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 YearsRecruitingNCT04373564Phase 4
- PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic StudiesRecruitingNCT04371042
- To Compare the Efficacy of Microwave Ablation and Laparoscopic Hepatectomy for Hepatocellular CarcinomaRecruitingNCT04365751Not applicable
- Prospective Cohort of Patients With Hepatocellular Carcinoma in FranceRecruitingNCT04348838
- Cohort of Patients With Hepatocellular Carcinoma or CholangiocarcinomaRecruitingNCT04340986
- Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor ThrombusNot yet recruitingNCT04319484Phase 2/3
- Prehabilitation and Posttransplant Training Program in Liver TransplantationEnrolling by invitationNCT04246970Not applicable
- Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/BevacizumabRecruitingNCT04224636Phase 2
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal CancersRecruitingNCT04221893Not applicable
- Cabozantinib to Treat Recurrent Liver Cancer Post TransplantRecruitingNCT04204850Phase 2
- A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC ClassificationRecruitingNCT04191889Phase 2
- Erlotinib for Hepatocellular Carcinoma ChemopreventionNot yet recruitingNCT04172779Phase 2
- Personalized DC Vaccine for Postoperative CancerRecruitingNCT04147078Phase 1
- HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized TrialRecruitingNCT04135690Phase 2
- Checkpoint Inhibition In Pediatric Hepatocellular CarcinomaRecruitingNCT04134559Phase 2
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor MalignanciesRecruitingNCT04114136Phase 2
- Hepatocarcinoma Recurrence on the Liver Study - Part2Not yet recruitingNCT04053231
- High Dose Vitamin C Combined With Metformin in the Treatment of Malignant TumorsRecruitingNCT04033107Phase 2
- Molecular Basis of Pediatric Liver CancerRecruitingNCT03959800
- Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver CancerRecruitingNCT03942328Phase 1/2
- Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCCRecruitingNCT03899428Phase 2
- Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver CarcinomaRecruitingNCT03895359Phase 3
- Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular CarcinomaRecruitingNCT03894917
- Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
- Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer PatientsRecruitingNCT03787056Not applicable
- Microwave Ablation Versus Liver Resection For Early Hepatocellular Carcinoma in Patients With Borderline Liver FunctionRecruitingNCT03766555Not applicable
- Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsRecruitingNCT03755739Phase 2/3
- Randomized Study of Adjuvant Radiotherapy After Curative Resection of HCC With Narrow Margin (RAISE)RecruitingNCT03732105Not applicable
- Y90 Radioembolization Dose Delivery and Radiation Exposure AssessmentRecruitingNCT03686709Not applicable
- The Overall Survival of Patients With Unresectable HCC in Real-lifeRecruitingNCT03612726
- Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal MalignanciesRecruitingNCT03539822Phase 1/2
- A Phase I/II Study of Regorafenib Plus Avelumab in Solid TumorsRecruitingNCT03475953Phase 1/2
- SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and RegistryRecruitingNCT03452774
- Determination of Autonomic Responses to the Exposure of Low Energy Electromagnetic Fields With Frequency Modulation in Patients With Advanced Hepatocellular Carcinoma and Healthy Individuals.RecruitingNCT03448757Not applicable
- A Study of PTS100 in Primary HCC PatientsRecruitingNCT03447951Phase 2
- A Study of Imaging, Blood, and Tissue Samples to Guide Treatment of Colon Cancer and Related Liver TumorsRecruitingNCT03432806
- The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.RecruitingNCT03368651Phase 3
- Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local AblationRecruitingNCT03356236
- Combination of TATE and PD-1 Inhibitor in Liver CancerRecruitingNCT03259867Phase 2
- Prospective Observational Trial to Evaluate Quality of Life After Stereotactic Ablative Radiation Therapy in Patients With Hepatocellular CarcinomaRecruitingNCT03253536
- GPC3-CAR-T Cells for Immunotherapy of Cancer With GPC3 ExpressionRecruitingNCT03198546Phase 1
- Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid TumorRecruitingNCT03093688Phase 1/2
- Combination Therapy of Microwave Ablation and Cellular Immunotherapy for Hepatocellular CarcinomaRecruitingNCT02851784Phase 2/3
- Laparoscopic Surgery VS RFA for Recurrent HCCNot yet recruitingNCT02785380Phase 4
- Oral Vitamin D Treatment for the Prevention of Hepatocellular CarcinomaNot yet recruitingNCT02779465Phase 4
- MiRNA as a Diagnostic and Prognostic Biomarker of Hepatocellular CarcinomaNot yet recruitingNCT02448056
- Dose-defining Study of Tirapazamine Combined With Embolization in Liver CancerRecruitingNCT02174549Phase 1/2
- Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver CancerEnrolling by invitationNCT02081755Phase 4
- Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal VaricesRecruitingNCT01970748Phase 4
- A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular CarcinomaTerminatedNCT05908786Phase 1/2Results posted
- SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAACompletedNCT05848947Phase 4Results posted
- Atezolizumab and Bevacizumab in Combination With TACE for Patients With BCLC B HCCTerminatedNCT05776875Phase 2Results posted
- Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral TherapyTerminatedNCT05717400Phase 4Results posted
- A Study of Amivantamab Monotherapy in Participants With Previously Treated Advanced Hepatocellular CarcinomaTerminatedNCT05653427Phase 2Results posted
- Study of [18F]FAPI-74 PET in Patients With Gastrointestinal CancersCompletedNCT05641896Phase 2Results posted
- Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic TherapyTerminatedNCT05630937Phase 1/2Results posted
- LOcoregional vs Systemic Therapy in Patients With BCLC Stage B HCCTerminatedNCT05537402Phase 2Results posted
- Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaTerminatedNCT05359861Phase 2Results posted
- A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerCompletedNCT05337137Phase 1/2Results posted
- A Study of SOT101 in Combination With Pembrolizumab to Evaluate the Efficacy and Safety in Patients With Selected Advanced Solid TumorsTerminatedNCT05256381Phase 2Results posted
- Study of Bavituximab, Axitinib, and Avelumab in Advanced Hepatocellular CarcinomaTerminatedNCT05249569Phase 2Results posted
- Regorafenib and Durvalumab for the Treatment of High-Risk Liver CancerActive, not recruitingNCT05194293Phase 2Results posted
- 68Ga PSMA PET Imaging for the Treatment of Advanced Liver CancerCompletedNCT05176223Phase 2Results posted
- A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Gastrointestinal Cancer (Master Protocol) (Pegathor Gastrointestinal 203)CompletedNCT05104567Phase 2Results posted
- A Study of E7386 in Combination With Pembrolizumab in Previously Treated Participants With Selected Solid TumorsCompletedNCT05091346Phase 1/2Results posted
- Study of PF-07263689 in Participants With Selected Advanced Solid TumorsTerminatedNCT05061537Phase 1Results posted
- Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantTerminatedNCT05027425Phase 2Results posted
- 18F-DCFPyL PET/CT in Hepatocellular CarcinomaTerminatedNCT05009979Phase 2Results posted
- MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)CompletedNCT05007106Phase 2Results posted
- A Study Investigating the Efficacy and Safety of Ociperlimab and Tislelizumab and BAT1706 Combinations in Patients With Advanced HCCCompletedNCT04948697Phase 2Results posted
- Hepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular CarcinomaCompletedNCT04945720Phase 2Results posted
- Adjuvant Radiotherapy for Resected Hepatocellular Carcinoma With MVICompletedNCT04891874Not applicableResults posted
- Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCCCompletedNCT04862949Results posted